Goodwin Procter advised Blueprint Medicines Corporation on the deal while Cooley represented Sixth Street. Blueprint Medicines Corporation (NASDAQ: BPMC) announced its strategic financing collaborations with Sixth...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Biospring Partners on the deal. Biospring Partners, a growth equity firm exclusively focused on business-to-business (B2B) life sciences technology companies, announced the closing of...
You must be a Standard 1 Year member to access this content.
Cooley advised Seae Ventures on the deal. Seae Ventures, a venture capital firm dedicated to advancing equity by investing in women and Black, Indigenous and people...
You must be a Standard 1 Year member to access this content.
Cooley advised Chingona Ventures on the deal. Chingona Ventures, a venture capital firm that invests in founders whose backgrounds uniquely position them to create businesses in...
You must be a Standard 1 Year member to access this content.
Cooley advised Elsewhere Partners on the deal. Growth-stage venture capital firm Elsewhere Partners announced the closing of its second fund, Elsewhere Partners II, with $175 million in...
You must be a Standard 1 Year member to access this content.
